Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,765 public trials 830 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

A Study of Auxora in Patients With Severe COVID-19 Pneumonia

NCT04345614

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations: Long Beach Memorial Long Beach, California, United States

University of Southern California / LA County Los Angeles, California, United States

Sharp Memorial San Diego San Diego, California, United States

National Jewish Health / St. Joseph's Hospital Denver, Colorado, United States

View all 17 locations

View Trial Details

Completed

Revealing Protective Immunity to Influenza Using Systems Immunology

NCT06501963

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Hope Clinic of the Emory Vaccine Center Decatur, Georgia, United States

View Trial Details

Completed

HIV HOspital TEsting: Bringing the Hidden to Light in the Hospital Setting

NCT06282328

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations: IRCCS San Raffaele Scientific Institute Milan, Italy

View Trial Details

Completed

Adherence to Anti-rabies Post-exposure Prophylactic Protocols

NCT07012083

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: Faculty of Medicine Tanta university Tanta, Gharbia Governorate, Egypt

View Trial Details

Completed

RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms

NCT05965726

Conditions: COVID-19, Chronic Disease, Coronaviridae Infections, +17 more
Locations: All sites listed under NCT05595369 Durham, North Carolina, United States

View Trial Details

Completed

Extended Follow-Up of the ISS T-003 Trial Volunteers (ISS T-003 EF-UP2020)

NCT05680948

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Mecru Clinical Research Unit (MeCRU) Medunsa, Gauteng, South Africa

View Trial Details

Completed

Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction

NCT05212610

Conditions: COVID-19, Corona Virus Infection, Coronaviridae Infections, +12 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Prevent TB: Choice Architecture for TPT Delivery

NCT04466488

Conditions: Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +20 more
Locations: Perinatal HIV Research Unit Soweto, Gauteng, South Africa

View Trial Details

Completed

Pharmacy-based PrEP Delivery in Kenya

NCT05842122

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Kenya Medical Research Institute Kisumu, Kenya

Partners in Health & Research Development Thika, Kenya

View Trial Details

Completed

Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda

NCT03919695

Conditions: Acquired Immunodeficiency Syndrome, Alcohol Use Disorder, Alcohol-Related Disorders, +20 more
Locations: selected Wakiso District HIV clinics Multiple Locations, Wakiso District, Uganda

View Trial Details

RNA Virus Infections

RNA Virus Infections trial results

Related conditions